Harmonizing Science & Data
Uncover life-changing discoveries with the world’s largest R&D platform.
Get a DemoKnow Everything, So You Can Discover Anything
Your scientists know what data is needed to advance research. Break down silos of information and give them the power to access it, share it, and trust it. This is how to accelerate the transformation of knowledge into beneficial innovations that improve humanity.
Get a Demo
More than 2 million researchers use our scientific solutions
Discover the World’s Largest R&D Platform
We believe science, data, and decision-making must be deeply intertwined so innovation can thrive.
The Dotmatics digital science platform provides the first true end-to-end solution for scientific R&D, combining an open data informatics framework with the most widely used applications for data analysis, biologics, flow cytometry, chemicals innovation, and more.
By providing powerful ways to gather, understand, use, and share research data across teams and experiments in your organization, your scientists can move faster and be more accurate.
Get the Best Insights From the Most Comprehensive Data
Discover the power of unifying best-in-breed software applications on a single data-centric platform. This is the future of collaboration, automation and analysis in science.
Best-in-Breed
Applications
Open Data Informatics Platform
Unparalleled
Insights
Explore Featured Capabilities for End-to-End Scientific Process Automation and Workflow Management
Assay Data
Management
Fully automate acquiring and processing instrument data, wherever it is located.
Electronic Lab
Notebook
Utilize a flexible and intelligent digital tool to easily capture and search all of your data.
Entity
Registration
Discover comprehensive provenance tracking and associated data management.
Serving Researchers at the Core of Scientific and Technical Innovation
“The Dotmatics group invested in our patient-first company vision immediately and we understood that our collaboration would immediately yield better science and discovery.”
Michael DiGruccio
M6P Therapeutics
